Spots Global Cancer Trial Database for immunocompromised
Every month we try and update this database with for immunocompromised cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) | NCT05026138 | Human Papilloma... | 3 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis | NCT02057289 | Immunocompromis... Bone Marrow Tra... Cancer | Micafungin | 6 Months - 10 Years | Children's Hospital Medical Center, Cincinnati | |
| ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals | NCT05655546 | Immunodeficienc... Immunosuppressi... HIV Infections Graft Versus Ho... Leukemia Lymphoma Cancer Multiple Myelom... Transplant Age-Related Imm... | Access to Cue H... | 18 Years - 120 Years | Scripps Translational Science Institute | |
| A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) | NCT01254630 | Herpes Zoster | V212 Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease | NCT03425526 | Hematopoietic a... Immunocompromis... | Allogeneic Aden... | - | M.D. Anderson Cancer Center | |
| Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy | NCT03168815 | Immunocompromis... Hematologic Mal... Post Hematopoie... Hypoxia Pulmonary Infil... | High Flow Nasal... | 18 Years - | Mount Sinai Hospital, Canada | |
| Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults | NCT04952766 | Kidney Transpla... Myeloma Cancer Hematologic Mal... Multiple Sclero... Hypergammaglobu... Malignant Tumor Hiv Diabetes Type 2 | Biological samp... | 18 Years - | Centre Hospitalier Régional d'Orléans | |
| A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis | NCT02057289 | Immunocompromis... Bone Marrow Tra... Cancer | Micafungin | 6 Months - 10 Years | Children's Hospital Medical Center, Cincinnati | |
| Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease | NCT03425526 | Hematopoietic a... Immunocompromis... | Allogeneic Aden... | - | M.D. Anderson Cancer Center | |
| Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) | NCT05026138 | Human Papilloma... | 3 Years - | National Institutes of Health Clinical Center (CC) | ||
| Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) | NCT05026138 | Human Papilloma... | 3 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) | NCT01254630 | Herpes Zoster | V212 Placebo | 18 Years - | Merck Sharp & Dohme LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
